Stephen Harper, MD
Otolaryngology · Winston Salem, NCNPI 1710967070
Payments from drug & device makers
What this record shows
Intersect ENT, Inc. accounts for 70.8% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $2,563 and has fallen 93.8% since, to $159 in 2025.
Across 61 payments — averaging $56.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$2K
- Sanofi$452
- Stryker$110
- GSK$102
- Masimo Corporation$96
- Optinose US, Inc.$80
- plus $172 from 8 others
Across 38 payments — averaging $2320.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aerin Medical Inc.$64K
- Stryker$19K
- Arrinex, Inc.$5K
What the payments were for
- Travel & lodging$1,68949%
- Food & beverage$1,77451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 12 | $2,451 |
| Sanofi | 18 | $452 |
| Stryker | 6 | $110 |
| GSK | 6 | $102 |
| Masimo Corporation | 3 | $96 |
| Optinose US, Inc. | 6 | $80 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Aerin Medical Inc. | 2 | $28 |
| KARL Storz Endoscopy-america | 1 | $28 |
| Merck | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Medtronic | 1 | $14 |
| Hospira, Inc. | 1 | $13 |
| Novartis | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,463 in reported general payments places this provider in the 80th percentile of 362 otolaryngology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinolone Acetonide Oil | 65 | $2,331 |
| Ipratropium Bromide | 68 | $1,225 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 13 | $595 |
| Fluticasone Propionate | 24 | $551 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $134 |
| Amoxicillin | 21 | $85 |
| Levothyroxine Sodium | 12 | $80 |
| Montelukast Sodium | 18 | $66 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Winston Salem
- Adam CampbellWinston Salem$47K
- William ScurryWinston Salem$19K
- James MimsWinston Salem$15K
- John BrittWinston Salem$4K
- Thomas FitzpatrickWinston Salem$4K
- David JangDurham$324K
- Robert FerrisRaleigh$258K
- Adam ZanationHickory$227K
- Brent SeniorChapel Hill$91K
- Charles EbertChapel Hill$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.